Alit Stark-Inbar
Overview
Explore the profile of Alit Stark-Inbar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hershey A, Shmuely S, Stark-Inbar A, Asmar Y, Ironi A, Strong E, et al.
Children (Basel)
. 2024 Nov;
11(11).
PMID: 39594861
Migraine affects 10% of adolescents and children. Typical school protocols in the USA require pharmacological medications to be administered by school nurses, often resulting in treatment delays or omissions when...
2.
Monteith T, Stark-Inbar A, Shmuely S, Harris D, Garas S, Ironi A, et al.
Front Pain Res (Lausanne)
. 2023 Nov;
4:1247313.
PMID: 38028429
Introduction: Migraine is a chronic neurological disease manifesting as attacks of disabling head pain and associated symptoms. Remote electrical neuromodulation (REN) is a non-pharmacological, prescribed, wearable device (Nerivio®). This device...
3.
Synowiec A, Stark-Inbar A, Weinstein M, Ironi A, Mauskop A
Adv Ther
. 2023 Oct;
41(1):170-181.
PMID: 37855973
Introduction: Migraine is a chronic neurological disorder causing severe pain and disability in more than a billion people worldwide. Ideal treatment should provide long-term efficacy with minimal side effects. Previous...
4.
Blumenfeld A, Rabany L, Ironi A, Stark-Inbar A, Harris D, Halker Singh R, et al.
Pain Manag
. 2023 Aug;
13(8):425-432.
PMID: 37615080
To evaluate the onset, magnitude and persistence of efficacy of remote electrical neuromodulation (REN) compared with placebo for the preventive treatment of migraine. Analysis was conducted on data from a...
5.
Peretz A, Stark-Inbar A, Harris D, Tamir S, Shmuely S, Ironi A, et al.
Headache
. 2023 Jun;
63(7):968-970.
PMID: 37335242
No abstract available.
6.
Cowan R, Stark-Inbar A, Rabany L, Harris D, Vizel M, Ironi A, et al.
J Med Econ
. 2023 Apr;
26(1):656-664.
PMID: 37083448
Aims: Assess the clinical benefits and associated direct and indirect cost-savings from Remote Electrical Neuromodulation (REN) for migraine prevention. Methods: REN, a prescribed, wearable, FDA-cleared neuromodulation-device for acute and/or preventive...
7.
Esparham A, Stark-Inbar A, Jekel L, Tamir S, Rabany L, Ironi A, et al.
Pediatr Neurol
. 2023 Mar;
142:51-55.
PMID: 36931109
Nearly 10% of children and adolescents in the United States experience migraine. Pharmacologic treatment of migraine in adolescents is limited due to only few US Food and Drug Administration (FDA)-approved...
8.
Tepper S, Rabany L, Cowan R, Smith T, Grosberg B, Torphy B, et al.
Headache
. 2023 Jan;
63(3):377-389.
PMID: 36704988
Objective: To assess the clinical efficacy of remote electrical neuromodulation (REN), used every other day, for the prevention of migraine. Background: Preventive treatment is key to managing migraine, but it...
9.
Grosberg B, Rabany L, Vizel M, Ironi A, Harris D, Stark-Inbar A, et al.
Pain Manag
. 2022 Sep;
12(7):837-844.
PMID: 36097974
The current study compared the effectiveness of remote electrical neuromodulation (REN) to that of standard-care medications for acute treatments of migraine, using a within-subjects design. within-subject analysis was performed on...
10.
Nierenburg H, Stark-Inbar A
Pain Manag
. 2021 Sep;
12(3):267-281.
PMID: 34538078
Nerivio (by Theranica Bio-Electronics Ltd, Tel Aviv, Israel) is a wireless, wearable, noninvasive, battery-operated, remote electrical neuromodulation device controlled by a smartphone application. It is US FDA authorized for the...